Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Investing in high-yield dividend stocks can provide stable passive income in retirement with our 8% yielding model portfolio.

Learn about CSHI, an ETF that invests in T-bills and S&P 500 option spreads for increased yields and income. Learn more about ...

UTG has recovered most losses since 2023, but its valuation remains high. Click here to read why I am neutral on UTG CEF.

Mercer International's (MERC) valuation metrics indicate it may be undervalued at its current share price, therefore I ...

Workiva's strong fundamentals include consistent mid-teens growth, improving net retention rates, and mission-critical ...

AMC Entertainment shifted $2.4 billion in 2026 debt maturities to 2029 and 2030. Click here to read why I have upgraded AMC ...

My strategy aims for a $50,000 annual income portfolio by age 40. Check out my Top 3 largest holdings that comprise just ...

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

JRI increased its distribution by over 33% to narrow its discount and fend off activists. Read why JRI CEF has been ...

Commonwealth Bank of Australia's ROE and dividend payout ratios were better than its key Australian banking peers. Read why I ...

Caterpillar has a profitable growth strategy, including expanded offerings and services. Read why I have upgraded CAT stock ...